Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? - Wikidata - awgldk - TriplyDB

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

http://www.wikidata.org/entity/Q39543532

about

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

http://www.wikidata.org/entity/Q39543532

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@en

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@nl

type

label

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@en

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@nl

prefLabel

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@en

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@nl

P1433

Q39543532-95FAAE4D-EF23-4AD5-A615-223E68738253

P1476

Q39543532-F365D517-A24C-44C4-82FF-781E020DC52E

P2093

Q39543532-04061819-374E-492A-80C3-5B3FEA4E1153

Q39543532-0C79B7C2-9970-48F6-9C38-46682FA9FF7D

Q39543532-4F4CB016-E777-4B74-BCEC-E7C82FAB7D1A

Q39543532-56681F61-DE58-4EFE-A0B0-715E632F4628

Q39543532-84296493-C6EB-49E7-BCE4-C1C5D8BEF7F4

Q39543532-A7CD06B4-47C4-4DC1-9C25-BEEA8E23A9E2

P2860

Q39543532-2CB503B0-98C1-4294-B03B-5AF9F400A120

Q39543532-37C7A3F7-FA24-43BB-BC2A-BAD9C7CD9C06

Q39543532-592F4880-A5BC-4911-AA59-D06522EB2938

Q39543532-976D969E-C5CD-4EC6-99F4-214608222697

Q39543532-BC59FD1F-C2DE-4ADD-9D3E-919E8625C49F

Q39543532-DCD919BD-F547-40F8-9469-F4102836F6DB

Q39543532-F0E9F314-2919-4628-B47A-5EB368A4FB19

P304

Q39543532-9A05E135-71F1-449D-A1F0-40759FF2D649

P31

Q39543532-7AB63DA6-CA30-4C7F-824A-ED2CBF6E8F6A

P356

Q39543532-3240B63D-DF70-42EB-ADC3-6F48B28CFCE9

P433

Q39543532-E7A5790F-792C-4AB4-BCB4-F9EEEFE28E60

P478

Q39543532-B962F4AE-6919-4812-9267-9F0D46B8F898

P577

Q39543532-B76F924E-66A1-4F7B-96CE-0AF4356FD024

P698

Q39543532-A228429D-7A4A-4589-A635-7898CCEF6E80

P356

J.1600-0463.2012.02943.X

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

@en

P2093

Claus K Høgdall

http://www.w3.org/2001/XMLSchema#string

Estrid V S Høgdall

http://www.w3.org/2001/XMLSchema#string

Ib J Christensen

http://www.w3.org/2001/XMLSchema#string

Lotte Nedergaard

http://www.w3.org/2001/XMLSchema#string

Mel C J Heeran

http://www.w3.org/2001/XMLSchema#string

Morten H Sparholt

http://www.w3.org/2001/XMLSchema#string

P2860

Modelling the molecular circuitry of cancer.

Immunohistochemistry in gynaecological pathology: a review.

Cancer antigen 125 and prognosis.

Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.

Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer.

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.

P304

38-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0463.2012.02943.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23030299

http://www.w3.org/2001/XMLSchema#string